Nature Biotechnology's academic spinouts 2021.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36329325.
- Also identified by DOI 10.1038/s41587-022-01530-9 and PMC identifier 9633025.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<i>Nature Biotechnology</i>’s annual survey highlights academic startups that are, among other things, designing circular RNA therapeutics, tackling cancer with arenaviruses, creating psychedelics without the trip, editing genes and cells in vivo, harnessing the power of autoantibodies and editing the epigenome.
Medical subject headings
- Biotechnology